Akahane Keiko, Shirai Katsuyuki, Wakatsuki Masaru, Ogawa Kazunari, Minato Kyosuke, Hamamoto Kohei, Takahashi Satoru, Suzuki Koichi, Takahashi Jun, Rikiyama Toshiki, Matsumoto Keita, Mashima Hirosato
Department of Radiology Saitama Medical Center Jichi Medical University Saitama Japan.
Department of Radiology Jichi Medical University Shimotsuke Japan.
Clin Case Rep. 2020 Mar 9;8(5):919-922. doi: 10.1002/ccr3.2751. eCollection 2020 May.
Antiangiogenic agents, such as ramucirumab, should be cautiously administered along with radiotherapy because of the enhanced risk of adverse events.
由于不良事件风险增加,抗血管生成药物(如雷莫西尤单抗)与放疗联合使用时应谨慎给药。